---
category: news
title: "Endeavor BioMedicines Partners with xCures to Identify Patients with PTCH1 mutations for Phase 2 Trial of ENV-101 (taladegib)"
excerpt: "Endeavor BioMedicines, a clinical-stage biotechnology company targeting the core drivers of terminal diseases including oncology and fibrosis, and xCures, a company that aims to improve cancer outcomes and accelerate cancer research using artificial intelligence,"
publishedDateTime: 2022-05-31T12:02:00Z
originalUrl: "https://apnews.com/press-release/BusinessWire/health-cancer-clinical-trials-db0246c05c1c48eaa0041e997b6cf5d8"
webUrl: "https://apnews.com/press-release/BusinessWire/health-cancer-clinical-trials-db0246c05c1c48eaa0041e997b6cf5d8"
type: article
quality: 0
heat: 0
published: false

provider:
  name: Associated Press
  domain: apnews.com

topics:
  - AI in Healthcare
  - AI

images:
  - url: "https://apnews.com/images/PaidContent3.png"
    width: 700
    height: 450
    isCached: true

secured: "Qmvflim96fUkEH5kHHYECglrh8swBtV23VhqVipTVfDAMAzYFOdVQBOnDiNaw2pzsEPi5P6M6yr9HhfhhFp9kTJD96+911khL0uUWZJI/dt3UNuxvEKSXg6VrNsa6N7fltjc2iz7sAmfMQ4gOPlpUiQJJuy1YAn6dZc3KZculvvPU8y0tqPp2RAsnh1NVy90FKctQBqRL6MkVN3vmuu3aZgshrpS9Znb6egsQqyrt1Lut83mvb4GDsiyYNoJrehx8RkgGktGTPVmCjOOKtVHcERZ3pd8It3kRflNLVEO/bK3ZmAuIvzMVhprCh2GSLqt+BXQqDVQgz1mOHz+76R5rymtnf7UIuEFC6amwHjkl9c=;qYaASxHyyl0B76JsJGozJA=="
---

